The insulin enhancer binding site 2 (IEB2; FAR) box of the insulin gene regulatory region binds at least three factors that can be distinguished by their DNA binding characteristics

M L Read, S B Smith, K Docherty

    Research output: Contribution to journalArticlepeer-review

    9 Citations (Scopus)

    Abstract

    Located at approximately 230 bp upstream from the transcription start site, the insulin enhancer binding site 2 (IEB2) or FAR region of the insulin gene is one of several important sequences involved in regulating transcription of the gene. The present study was undertaken to characterize the transcription factors binding at the IEB2/FAR region of the rat insulin II gene and to compare these with factors known to bind to the equivalent sequence in the rat I and human insulin genes. An endocrine-enriched factor, EFD3, was identified, which bound to the sequence CAGGAG. A second factor (D4) was identified as the widely expressed factor USF (upstream stimulating factor), while a third factor (D5) remained largely uncharacterized. The binding affinities of these three factors differed in the three genes, suggesting that the role of the IEB2/FAR sequence may vary subtly between the rat insulin II, rat insulin I and human insulin genes.

    Original languageEnglish
    Pages (from-to)231-6
    Number of pages6
    JournalBiochemical Journal
    Volume309 ( Pt 1)
    Publication statusPublished - 1 Jul 1995

    Keywords

    • Animals
    • Base Sequence
    • Cell Line
    • Cricetinae
    • DNA
    • DNA-Binding Proteins
    • Enhancer Elements, Genetic
    • Humans
    • Insulin
    • Mesocricetus
    • Mice
    • Molecular Sequence Data
    • Rats
    • Regulatory Sequences, Nucleic Acid

    Fingerprint

    Dive into the research topics of 'The insulin enhancer binding site 2 (IEB2; FAR) box of the insulin gene regulatory region binds at least three factors that can be distinguished by their DNA binding characteristics'. Together they form a unique fingerprint.

    Cite this